Yongfeng Yang
- Hepatology top 5%
- Liver Diseases and Immunity 10
- Hepatitis C virus research 7
- Hepatocellular Carcinoma Treatment and Prognosis 4
-
- Cancer, Hypoxia, and Metabolism 4
-
- Liver Disease Diagnosis and Treatment 17
- Hepatitis B Virus Studies 9
-
- Advanced biosensing and bioanalysis techniques 4
-
- Pediatric Hepatobiliary Diseases and Treatments 5
- Partner nations
- ChinaUnited StatesBangladesh
In The Last Decade
Yongfeng Yang
55 papers receiving 634 citations
Peers
Comparison fields: 5 of 99
- Hepatology 119
- Cancer Research 103
- Epidemiology 210
- Electrochemistry 23
- Molecular Biology 256
Countries citing papers authored by Yongfeng Yang
This map shows the geographic impact of Yongfeng Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yongfeng Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yongfeng Yang more than expected).
Fields of papers citing papers by Yongfeng Yang
This network shows the impact of papers produced by Yongfeng Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yongfeng Yang. The network helps show where Yongfeng Yang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yongfeng Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 15 | |
| 6 | 2023 | 1 | |
| 7 | 2023 | 5 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 0 | |
| 10 | 2021 | 11 | |
| 11 | 2021 | 6 | |
| 12 | 2020 | 10 | |
| 13 | 2020 | 2 | |
| 14 | 2019 | 82 | |
| 15 | 2019 | 10 | |
| 16 | 2019 | 19 | |
| 17 | 2018 | 14 | |
| 18 | 2018 | 34 | |
| 19 | MicroRNA-497 regulates cisplatin chemosensitivity of cervical cancer by targeting transketolase. | 2016 | 48 |
| 20 | 2013 | 2 |
About Yongfeng Yang
Yongfeng Yang is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 65 papers that have together received 643 indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (17 papers), Liver Diseases and Immunity (10 papers), Hepatitis B Virus Studies (9 papers), Hepatitis C virus research (7 papers), Pediatric Hepatobiliary Diseases and Treatments (5 papers), Cancer, Hypoxia, and Metabolism (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (4 papers) and Advanced biosensing and bioanalysis techniques (4 papers). The work is most often cited by research in Hepatology (119 citations), Cancer Research (103 citations) and Epidemiology (210 citations). Yongfeng Yang has collaborated with scholars based in China, United States and Bangladesh. Frequent co-authors include Xing‐Jie Liang, Yuanyu Huang, Jie Yu, Yuhua Weng, Xiaoxia Wang, Chunhui Li, Qianqian Huang, Xuping Wu, Hongxia Wei and Zhiliang Hu. Their work appears in journals such as The Journal of Immunology, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.